EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

Oncotarget · 2014 · PMC3964213 · PMID 24495907

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Although we had a limited number of samples, a clear trend could be observed towards an increased expression of EFEMP1 in glioblastoma samples at the time of progression (Fig. 6C ), suggesting that EFEMP1 could be used as a marker for tumor progression after TMZ treatment.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.